8-KThe WireRoutine
Bylaw Amendment
Filed Feb 16, 2021 · 5y ago · Accession 0001193125-21-044889
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Amneal Pharmaceuticals, Inc.
- Ticker
- AMRX
- CIK
- 1723128
- Form type
- 8-K
- Filing date
- Feb 16, 2021
- Report date
- Feb 12, 2021
- Document
- d126979d8k.htm
- Size
- 449 KB